In the next Front Row lecture, Darrell Irvine explains how controlling where vaccine components travel in the body, and when and for how long they’re delivered, can lead to stronger, longer-lasting immune responses. Hear how two approaches from his lab, a new vaccine adjuvant and a gradual dosing strategy, are moving into clinical testing. Grab a seat for November 18!
Associate Professor Adjunct
Department of Integrative Structural and Computational Biology
No more annual flu shot? Scripps Research and collaborators find new target for universal influenza vaccine
A new antibody discovered in the blood of some people vaccinated against or infected with influenza can recognize a broad variety of flu viruses.